DECLINED PRESENTATION DENDRITIC CELL VACCINATION AS A POST-REMISSION TREATMENT IN ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Berneman, Zwi [1 ]
Van de Velde, Ann [1 ]
Anguille, Sebastien [1 ]
Nijs, Griet [1 ]
Stein, Barbara [1 ]
Cools, Nathalie [1 ]
Vermeulen, Katrien [1 ]
Maes, Marie-Berthe [1 ]
Willemen, Yannick [1 ]
Granacher, Nikki [1 ]
Lammens, Martin [1 ]
Van Tendeloo, Viggo [1 ]
Smits, Evelien [1 ]
机构：
[1] Univ Antwerp Hosp, Edegem, Belgium
来源：
EXPERIMENTAL HEMATOLOGY | 2015年 / 43卷 / 09期
关键词：
D O I：
10.1016/j.exphem.2015.06.083
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3009
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [41] Impact of Post-Remission Consolidation Modalities in the Clinical Outcomes of Acute Myeloid Leukemia Patients in First Remission - Is There a Role for Autologous Hematopoietic Stem Cell Transplant?
    Cheong, May Anne
    Wong, Gee Chuan
    Hwang, William Y. K.
    Aloysius, Ho Y. L.
    Linn, Yeh Ching
    Goh, Yeow Tee Y. T.
    Loh, Yvonne
    Kumar, Sathish
    Phipps, Colin
    Lao, Zhentang
    [J]. BLOOD, 2015, 126 (23)
  • [42] Can allogeneic stem cell hematopoietic transplant with any type of donor be the standard post-remission treatment in intermediate-risk acute myeloid leukemia in first complete remission?
    Cerezo Martin, J. M.
    Bermudez-Rodriguez, A.
    Colorado, M. D. L. M.
    Munoz, P.
    Fernandez-Luis, S.
    Yanez, L.
    Martin, G.
    Fernandez, N.
    Calvo, J. A.
    Insunza Gaminde, A.
    Montes, C.
    Gonzalez, S.
    Batlle, A.
    Briz, M.
    Romon, I.
    Sanchez-Escamilla, M.
    Arroyo, J. L.
    Ocio, E.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 112 - 113
  • [43] The role of post-remission chemotherapy for older patients with acute myelogenous leukemia
    Abou-Jawde, RM
    Sobecks, R
    Pohlman, B
    Rybicki, L
    Advani, A
    Sekeres, M
    Kalaycio, M
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (04) : 689 - 695
  • [44] Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia
    Bahashwan, Salem
    Molucon-Chabrot, Cecile
    Hermet, Eric
    Ravinet, Aurelie
    Douge, Aurore
    Veronese, Lauren
    Tchirkov, Andrei
    Lemal, Richard
    Berger, Marc G.
    Veyrat-Masson, Richard
    Tournilhac, Olivier
    Bay, Jacques-Olivier
    Guieze, Romain
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (01) : E32 - E35
  • [45] Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years
    J J Cornelissen
    J Versluis
    J R Passweg
    W L J van Putten
    M G Manz
    J Maertens
    H B Beverloo
    P J M Valk
    M van Marwijk Kooy
    P W Wijermans
    M R Schaafsma
    B J Biemond
    M-C Vekemans
    D A Breems
    L F Verdonck
    M F Fey
    M Jongen-Lavrencic
    J J W M Janssen
    G Huls
    J Kuball
    T Pabst
    C Graux
    H C Schouten
    A Gratwohl
    E Vellenga
    G Ossenkoppele
    B Löwenberg
    [J]. Leukemia, 2015, 29 : 1041 - 1050
  • [46] A randomized study of fludarabine in part of induction and post-remission treatment for de novo acute myeloid leukemia (AML) in elderly patients.
    Witz, F
    Harousseau, JL
    Sadoun, A
    Cahn, JY
    Le Prise, PY
    Tournilihac, O
    Desablens, B
    Guyotat, D
    Vilque, JP
    Berthou, C
    Solary, E
    Ojeda, M
    Casassus, P
    Francois, S
    Delain, M
    Dorvaux, V
    Raby, P
    Guibon, O
    Berthaud, P
    Liqure, B
    [J]. BLOOD, 2000, 96 (11) : 504A - 504A
  • [47] A Dose-Finding Study of Lenalidomide As Post-Remission Therapy for Older Adults with Acute Myeloid Leukemia (AML)
    Foster, Matthew C.
    Van Deventer, Hendrik W.
    Jamieson, Katarzyna
    Vincent, Benjamin G.
    Matson, Melissa
    McKinnon, Karen
    Reisdorf, Shannon
    Zhang, Jack
    Pulley, Will
    Muss, Hyman
    Ivanova, Anastasia
    Zeidner, Joshua F.
    [J]. BLOOD, 2017, 130
  • [48] Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy
    Thomas, X
    Le, QH
    De Botton, S
    Raffoux, E
    Chelghoum, Y
    Pautas, C
    Dreyfus, F
    Dhedin, N
    Vekhoff, A
    Troncy, J
    Pigneux, A
    De Revel, T
    Reman, O
    Travade, P
    Thiebaut, A
    Guerci, A
    Elhamri, M
    Fenaux, P
    Dombret, H
    Michallet, M
    [J]. LEUKEMIA & LYMPHOMA, 2005, 46 (07) : 1007 - 1016
  • [49] Outcome after Midam Regimen and Impact of Post-Remission Strategy in Patients with Relapsing or Refractory Acute Myeloid Leukemia
    Bahashwan, Salem
    Molucon-Chabrot, Cecile
    Hermet, Eric
    Ravinet, Aurelie
    Douge, Aurore
    Veronese, Lauren
    Tchirkov, Andrei
    Lemal, Richard
    Berger, Marc G.
    Tournilhac, Olivier
    Bay, Jacques-Olivier
    Guieze, Romain
    [J]. BLOOD, 2017, 130
  • [50] Autologous Stem Cell Transplant (ASCT) As an Effective Post-Remission Consolidation Strategy for Good Risk Acute Myeloid Leukemia (AML) Patients
    Cerny, Jan
    Ramanathan, Muthalagu
    Evens, Andrew
    Walsh, William
    Rosmarin, Alan
    Nath, Rajneesh
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S227 - S228
12345